Different glucosamine sulfate products generate different outcomes on osteoarthritis symptoms. (2018)
Attributed to:
Lifecourse Determinants of Bone and Joint Disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/annrheumdis-2017-212251
PubMed Identifier: 28877867
Publication URI: http://europepmc.org/abstract/MED/28877867
Type: Journal Article/Review
Volume: 77
Parent Publication: Annals of the rheumatic diseases
Issue: 7
ISSN: 0003-4967